1062 related articles for article (PubMed ID: 33907315)
1. Therapeutic cancer vaccines.
Saxena M; van der Burg SH; Melief CJM; Bhardwaj N
Nat Rev Cancer; 2021 Jun; 21(6):360-378. PubMed ID: 33907315
[TBL] [Abstract][Full Text] [Related]
2. Combining Cancer Vaccines with Immunotherapy: Establishing a New Immunological Approach.
Kim CG; Sang YB; Lee JH; Chon HJ
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360800
[TBL] [Abstract][Full Text] [Related]
3. Development of tumour peptide vaccines: From universalization to personalization.
Ma M; Liu J; Jin S; Wang L
Scand J Immunol; 2020 Jun; 91(6):e12875. PubMed ID: 32090366
[TBL] [Abstract][Full Text] [Related]
4. DNA vaccines to attack cancer: Strategies for improving immunogenicity and efficacy.
Tiptiri-Kourpeti A; Spyridopoulou K; Pappa A; Chlichlia K
Pharmacol Ther; 2016 Sep; 165():32-49. PubMed ID: 27235391
[TBL] [Abstract][Full Text] [Related]
5. Neoantigen vaccine platforms in clinical development: understanding the future of personalized immunotherapy.
Supabphol S; Li L; Goedegebuure SP; Gillanders WE
Expert Opin Investig Drugs; 2021 May; 30(5):529-541. PubMed ID: 33641576
[TBL] [Abstract][Full Text] [Related]
6. Methods for improving the immunogenicity and efficacy of cancer vaccines.
Pilla L; Ferrone S; Maccalli C
Expert Opin Biol Ther; 2018 Jul; 18(7):765-784. PubMed ID: 29874943
[TBL] [Abstract][Full Text] [Related]
7. Beyond Just Peptide Antigens: The Complex World of Peptide-Based Cancer Vaccines.
Stephens AJ; Burgess-Brown NA; Jiang S
Front Immunol; 2021; 12():696791. PubMed ID: 34276688
[TBL] [Abstract][Full Text] [Related]
8. At the bench: Engineering the next generation of cancer vaccines.
Shae D; Baljon JJ; Wehbe M; Becker KW; Sheehy TL; Wilson JT
J Leukoc Biol; 2020 Oct; 108(4):1435-1453. PubMed ID: 31430398
[TBL] [Abstract][Full Text] [Related]
9. Poxvirus-based vaccines for cancer immunotherapy: new insights from combined cytokines/co-stimulatory molecules delivery and "uncommon" strains.
Izzi V; Buler M; Masuelli L; Giganti MG; Modesti A; Bei R
Anticancer Agents Med Chem; 2014 Feb; 14(2):183-9. PubMed ID: 24237219
[TBL] [Abstract][Full Text] [Related]
10. DNA vaccine for cancer immunotherapy.
Yang B; Jeang J; Yang A; Wu TC; Hung CF
Hum Vaccin Immunother; 2014; 10(11):3153-64. PubMed ID: 25625927
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic Cancer Vaccine and Combinations With Antiangiogenic Therapies and Immune Checkpoint Blockade.
Mougel A; Terme M; Tanchot C
Front Immunol; 2019; 10():467. PubMed ID: 30923527
[TBL] [Abstract][Full Text] [Related]
12. Emerging trends in the immunotherapy of pancreatic cancer.
Banerjee K; Kumar S; Ross KA; Gautam S; Poelaert B; Nasser MW; Aithal A; Bhatia R; Wannemuehler MJ; Narasimhan B; Solheim JC; Batra SK; Jain M
Cancer Lett; 2018 Mar; 417():35-46. PubMed ID: 29242097
[TBL] [Abstract][Full Text] [Related]
13. Antitumour immune response and cancer vaccination: the critical role of dendritic cells.
Kochman S; Bernard J
Curr Med Res Opin; 1999; 15(4):321-6. PubMed ID: 10640266
[TBL] [Abstract][Full Text] [Related]
14. The Changing Landscape of Therapeutic Cancer Vaccines-Novel Platforms and Neoantigen Identification.
Jou J; Harrington KJ; Zocca MB; Ehrnrooth E; Cohen EEW
Clin Cancer Res; 2021 Feb; 27(3):689-703. PubMed ID: 33122346
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic cancer vaccines: From initial findings to prospects.
Song Q; Zhang CD; Wu XH
Immunol Lett; 2018 Apr; 196():11-21. PubMed ID: 29407608
[TBL] [Abstract][Full Text] [Related]
16. Vaccines for established cancer: overcoming the challenges posed by immune evasion.
van der Burg SH; Arens R; Ossendorp F; van Hall T; Melief CJ
Nat Rev Cancer; 2016 Apr; 16(4):219-33. PubMed ID: 26965076
[TBL] [Abstract][Full Text] [Related]
17. Whole cell vaccines--past progress and future strategies.
Keenan BP; Jaffee EM
Semin Oncol; 2012 Jun; 39(3):276-86. PubMed ID: 22595050
[TBL] [Abstract][Full Text] [Related]
18. Cancer vaccines: between the idea and the reality.
Finn OJ
Nat Rev Immunol; 2003 Aug; 3(8):630-41. PubMed ID: 12974478
[TBL] [Abstract][Full Text] [Related]
19. Recent developments in therapeutic cancer vaccines.
Morse MA; Chui S; Hobeika A; Lyerly HK; Clay T
Nat Clin Pract Oncol; 2005 Feb; 2(2):108-13. PubMed ID: 16264883
[TBL] [Abstract][Full Text] [Related]
20. IL-13 receptor-directed cancer vaccines and immunotherapy.
Nakashima H; Husain SR; Puri RK
Immunotherapy; 2012 Apr; 4(4):443-51. PubMed ID: 22512637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
